Advertisement
Surgical Pathology Clinics

Urothelial Carcinoma

Divergent Differentiation and Morphologic Subtypes
  • Author Footnotes
    1 Two authors contributed equally.
    Jatin Gandhi
    Footnotes
    1 Two authors contributed equally.
    Affiliations
    Department of Pathology and Laboratory Medicine, Emory University School of Medicine, 1364 Clifton Rd, Atlanta, GA 30322, USA
    Search for articles by this author
  • Author Footnotes
    1 Two authors contributed equally.
    Jie-Fu Chen
    Footnotes
    1 Two authors contributed equally.
    Affiliations
    Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Search for articles by this author
  • Hikmat Al-Ahmadie
    Correspondence
    Corresponding author. Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065
    Affiliations
    Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Search for articles by this author
  • Author Footnotes
    1 Two authors contributed equally.
Published:October 12, 2022DOI:https://doi.org/10.1016/j.path.2022.07.003

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgical Pathology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bray F.
        • Ferlay J.
        • Soerjomataram I.
        • et al.
        Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA Cancer J Clin. 2018; 68: 394-424
        • Saginala K.
        • Barsouk A.
        • Aluru J.S.
        • et al.
        Epidemiology of Bladder Cancer.
        Med Sci (Basel). 2020; 8
        • Siegel R.L.
        • Miller K.D.
        • Jemal A.
        Cancer statistics, 2020.
        CA Cancer J Clin. 2020; 70: 7-30
        • Wasco M.J.
        • Daignault S.
        • Zhang Y.
        • et al.
        Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection.
        Urology. 2007; 70: 69-74
        • Cai T.
        • Tiscione D.
        • Verze P.
        • et al.
        Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens.
        Urology. 2014; 84: 1141-1146
        • Moch H.
        • Humphrey P.A.
        • Ulbright T.M.
        • et al.
        Urinary and male genital tumours.
        International Agency for Research on Cancer, Lyon (France)2016 (WHO classification of tumours series, 4th ed.; vol. 8). Available at:
        • Comperat E.
        • Oszwald A.
        • Wasinger G.
        • et al.
        Updated pathology reporting standards for bladder cancer: biopsies, transurethral resections and radical cystectomies.
        World J Urol. 2022; 40: 915-927
        • Comperat E.
        • Amin M.B.
        • Epstein J.I.
        • et al.
        The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers.
        Adv Anat Pathol. 2021; 28: 196-208
        • Board. WCoTE
        Urinary and male genital tumours.
        International Agency for Research on Cancer, Lyon (France)2022 (WHO classification of tumours series, 5th ed.; vol. 8). Available at:
        • Amin M.B.
        Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications.
        Mod Pathol. 2009; 22: S96-S118
        • Kim S.P.
        • Frank I.
        • Cheville J.C.
        • et al.
        The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
        J Urol. 2012; 188: 405-409
        • Robertson A.G.
        • Kim J.
        • Al-Ahmadie H.
        • et al.
        Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.
        Cell. 2017; 171: 540-556 e25
        • Warrick J.I.
        • Sjodahl G.
        • Kaag M.
        • et al.
        Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants.
        Eur Urol. 2019; 75: 18-22
        • Bontoux C.
        • Rialland T.
        • Cussenot O.
        • et al.
        A four-antibody immunohistochemical panel can distinguish clinico-pathological clusters of urothelial carcinoma and reveals high concordance between primary tumor and lymph node metastases.
        Virchows Arch. 2021; 478: 637-645
        • Al-Ahmadie H.
        • Netto G.J.
        Molecular Pathology of Urothelial Carcinoma.
        Surg Pathol Clin. 2021; 14: 403-414
        • Ehdaie B.
        • Maschino A.
        • Shariat S.F.
        • et al.
        Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy.
        J Urol. 2012; 187: 74-79
        • Xylinas E.
        • Rink M.
        • Robinson B.D.
        • et al.
        Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
        Eur J Cancer. 2013; 49: 1889-1897
        • Park S.
        • Reuter V.E.
        • Hansel D.E.
        Non-urothelial carcinomas of the bladder.
        Histopathology. 2019; 74: 97-111
        • Blochin E.B.
        • Park K.J.
        • Tickoo S.K.
        • et al.
        Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection.
        Mod Pathol. 2012; 25: 1534-1542
        • Rogers C.G.
        • Palapattu G.S.
        • Shariat S.F.
        • et al.
        Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
        J Urol. 2006; 175 ([discussion: 2053]): 2048-2053
        • El-Bolkainy M.N.
        • Mokhtar N.M.
        • Ghoneim M.A.
        • et al.
        The impact of schistosomiasis on the pathology of bladder carcinoma.
        Cancer. 1981; 48: 2643-2648
        • el-Sebai I.
        • Sherif M.
        • el-Bolkainy M.N.
        • et al.
        Verrucose squamous carcinoma of bladder.
        Urology. 1974; 4: 407-410
        • Batta A.G.
        • Engen D.E.
        • Reiman H.M.
        • et al.
        Intravesical condyloma acuminatum with progression to verrucous carcinoma.
        Urology. 1990; 36: 457-464
        • Walther M.
        • O'Brien 3rd, D.P.
        • Birch H.W.
        Condylomata acuminata and verrucous carcinoma of the bladder: case report and literature review.
        J Urol. 1986; 135: 362-365
        • Vail E.
        • Zheng X.
        • Zhou M.
        • et al.
        Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladder.
        Ann Diagn Pathol. 2015; 19: 301-305
        • Almassi N.
        • Whiting K.
        • Toubaji A.
        • et al.
        Clinical and genomic characterization of bladder carcinomas with glandular phenotype.
        JCO Precis Oncol. 2022; 6: e2100392
        • Wang H.L.
        • Lu D.W.
        • Yerian L.M.
        • et al.
        Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.
        Am J Surg Pathol. 2001; 25: 1380-1387
        • Raspollini M.R.
        • Nesi G.
        • Baroni G.
        • et al.
        Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder.
        Appl Immunohistochem Mol Morphol. 2005; 13: 358-362
        • Roy S.
        • Pradhan D.
        • Ernst W.L.
        • et al.
        Next-generation sequencing-based molecular characterization of primary urinary bladder adenocarcinoma.
        Mod Pathol. 2017; 30: 1133-1143
        • Lughezzani G.
        • Sun M.
        • Jeldres C.
        • et al.
        Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
        Urology. 2010; 75: 376-381
        • Oliva E.
        • Amin M.B.
        • Jimenez R.
        • et al.
        Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
        Am J Surg Pathol. 2002; 26: 190-197
        • Sung M.T.
        • Zhang S.
        • MacLennan G.T.
        • et al.
        Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin.
        Clin Cancer Res. 2008; 14: 1947-1955
        • Kosem M.
        • Sengul E.
        Clear cell adenocarcinoma of the urinary bladder.
        Scand J Urol Nephrol. 2005; 39: 89-92
        • Ortiz-Bruchle N.
        • Wucherpfennig S.
        • Rose M.
        • et al.
        Molecular Characterization of Muellerian Tumors of the Urinary Tract.
        Genes (Basel). 2021; 12: 880
        • Chan E.O.
        • Chan V.W.
        • Poon J.Y.
        • et al.
        Clear cell carcinoma of the urinary bladder: a systematic review.
        Int Urol Nephrol. 2021; 53: 815-824
        • Taylor A.S.
        • Mehra R.
        • Udager A.M.
        Glandular Tumors of the Urachus and Urinary Bladder: A Practical Overview of a Broad Differential Diagnosis.
        Arch Pathol Lab Med. 2018; 142: 1164-1176
        • Balbas-Martinez C.
        • Rodriguez-Pinilla M.
        • Casanova A.
        • et al.
        ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors.
        PLoS One. 2013; 8: e62483
        • Lin C.Y.
        • Saleem A.
        • Stehr H.
        • et al.
        Molecular profiling of clear cell adenocarcinoma of the urinary tract.
        Virchows Arch. 2019; 475: 727-734
        • Rammal R.
        • Toubaji A.
        • Sarungbam J.
        • et al.
        Molecular Profiling of Clear Cell Adenocarcinoma of the Urinary Tract. Abstracts from USCAP 2021: Genitourinary Pathology (Including Renal Tumors) (422-531).
        Mod Pathol. 2021; 34: 647-766
        • Chang M.T.
        • Penson A.
        • Desai N.B.
        • et al.
        Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis.
        Clin Cancer Res. 2018; 24: 1965-1973
        • Veskimae E.
        • Espinos E.L.
        • Bruins H.M.
        • et al.
        What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review.
        Eur Urol Oncol. 2019; 2: 625-642
        • Chen J.F.
        • Yang C.
        • Sun Y.
        • et al.
        Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.
        Pathol Res Pract. 2020; 216: 152993
        • Kim Jr., I.E.
        • Amin A.
        • Wang L.J.
        • et al.
        Insulinoma-associated Protein 1 (INSM1) Expression in Small Cell Neuroendocrine Carcinoma of the Urinary Tract.
        Appl Immunohistochem Mol Morphol. 2020; 28: 687-693
        • Baine M.K.
        • Hsieh M.S.
        • Lai W.V.
        • et al.
        SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization.
        J Thorac Oncol. 2020; 15: 1823-1835
        • Akbulut D.
        • Jia L.
        • Ozcan G.G.
        • et al.
        Comprehensive Profiling of Neuroendocrine Carcinomas of the Bladder with Expanded Neuroendocrine Markers ASCL1, NEUROD1, POU2F3, YAP1 and DLL3. USCAP 2022 Abstracts: Genitourinary Pathology (including renal tumors) (522-659).
        Mod Pathol. 2022; 35: 657-806
        • Yang G.
        • Bondaruk J.
        • Cogdell D.
        • et al.
        Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer.
        iScience. 2020; 23: 101201
        • Hoffman-Censits J.
        • Choi W.
        • Pal S.
        • et al.
        Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression Profile.
        Eur Urol Oncol. 2021; 4: 297-300
        • Zheng X.
        • Zhuge J.
        • Bezerra S.M.
        • et al.
        High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins.
        J Hematol Oncol. 2014; 7: 47
        • Lynch S.P.
        • Shen Y.
        • Kamat A.
        • et al.
        Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center.
        Eur Urol. 2013; 64: 307-313
        • Guercio B.J.
        • Gandhi J.
        • Teo M.Y.
        • et al.
        Large cell neuroendocrine carcinoma of the urothelial tract (LNEC): The MSKCC experience.
        J Clin Oncol. 2021; 39: 4526
        • Cheng H.L.
        • Chou L.P.
        • Tsai H.W.
        • et al.
        Urothelial carcinoma with trophoblastic differentiation: Reappraisal of the clinical implication and immunohistochemically features.
        Urol Oncol. 2021; 39: 732.e17-23
        • Przybycin C.G.
        • McKenney J.K.
        • Nguyen J.K.
        • et al.
        Urothelial Carcinomas With Trophoblastic Differentiation, Including Choriocarcinoma: Clinicopathologic Series of 16 Cases.
        Am J Surg Pathol. 2020; 44: 1322-1330
        • Martin J.E.
        • Jenkins B.J.
        • Zuk R.J.
        • et al.
        Human chorionic gonadotrophin expression and histological findings as predictors of response to radiotherapy in carcinoma of the bladder.
        Virchows Arch A Pathol Anat Histopathol. 1989; 414: 273-277
        • Sangoi A.R.
        • Beck A.H.
        • Amin M.B.
        • et al.
        Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists.
        Am J Surg Pathol. 2010; 34: 1367-1376
        • Sangoi A.R.
        • Cox R.M.
        • Higgins J.P.
        • et al.
        Non-invasive papillary urothelial carcinoma with 'micropapillary' architecture: clinicopathological study of 18 patients emphasising clinical outcomes.
        Histopathology. 2020; 77: 728-733
        • Guo C.C.
        • Dadhania V.
        • Zhang L.
        • et al.
        Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.
        Eur Urol. 2016; 70: 611-620
        • Isharwal S.
        • Huang H.
        • Nanjangud G.
        • et al.
        Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma.
        Hum Pathol. 2018; 77: 63-69
        • Kamoun A.
        • de Reynies A.
        • Allory Y.
        • et al.
        A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.
        Eur Urol. 2020; 77: 420-433
        • Ross J.S.
        • Wang K.
        • Gay L.M.
        • et al.
        A high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinoma.
        Clin Cancer Res. 2014; 20: 68-75
        • Tschui J.
        • Vassella E.
        • Bandi N.
        • et al.
        Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer.
        Virchows Arch. 2015; 466: 703-710
        • Fairey A.S.
        • Daneshmand S.
        • Wang L.
        • et al.
        Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy.
        Urol Oncol. 2014; 32: 110-116
        • Mitra A.P.
        • Fairey A.S.
        • Skinner E.C.
        • et al.
        Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation.
        Urol Oncol. 2019; 37: 48-56
        • Wang J.K.
        • Boorjian S.A.
        • Cheville J.C.
        • et al.
        Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis.
        World J Urol. 2012; 30: 801-806
        • Nigwekar P.
        • Tamboli P.
        • Amin M.B.
        • et al.
        Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases.
        Am J Surg Pathol. 2009; 33: 417-424
        • Teo M.Y.
        • Al-Ahmadie H.
        • Seier K.
        • et al.
        Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma.
        Br J Cancer. 2021; 124: 1214-1221
        • Keck B.
        • Wach S.
        • Stoehr R.
        • et al.
        Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy.
        BMC Cancer. 2013; 13: 71
        • Al-Ahmadie H.A.
        • Iyer G.
        • Lee B.H.
        • et al.
        Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.
        Nat Genet. 2016; 48: 356-358
        • Sangoi A.R.
        • Chan E.
        • Stohr B.A.
        • et al.
        Invasive plasmacytoid urothelial carcinoma: A comparative study of E-cadherin and P120 catenin.
        Hum Pathol. 2020; 102: 54-59
        • Penson A.
        • Camacho N.
        • Zheng Y.
        • et al.
        Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care.
        JAMA Oncol. 2020; 6: 84-91
        • Drew P.A.
        • Furman J.
        • Civantos F.
        • et al.
        The nested variant of transitional cell carcinoma: an aggressive neoplasm with innocuous histology.
        Mod Pathol. 1996; 9: 989-994
        • Comperat E.
        • McKenney J.K.
        • Hartmann A.
        • et al.
        Large nested variant of urothelial carcinoma: a clinicopathological study of 36 cases.
        Histopathology. 2017; 71: 703-710
        • Cox R.
        • Epstein J.I.
        Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma.
        Am J Surg Pathol. 2011; 35: 1337-1342
        • Wasco M.J.
        • Daignault S.
        • Bradley D.
        • et al.
        Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases.
        Hum Pathol. 2010; 41: 163-171
        • Dhall D.
        • Al-Ahmadie H.
        • Olgac S.
        Nested variant of urothelial carcinoma.
        Arch Pathol Lab Med. 2007; 131: 1725-1727
        • Volmar K.E.
        • Chan T.Y.
        • De Marzo A.M.
        • et al.
        Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma.
        Am J Surg Pathol. 2003; 27: 1243-1252
        • Weyerer V.
        • Weisser R.
        • Moskalev E.A.
        • et al.
        Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma.
        Histopathology. 2019; 75: 865-875
        • Weyerer V.
        • Eckstein M.
        • Comperat E.
        • et al.
        Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an FGFR3 Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary Phenotype.
        Cancers (Basel). 2020; 12
        • Johnson S.M.
        • Khararjian A.
        • Legesse T.B.
        • et al.
        Nested Variant of Urothelial Carcinoma Is a Luminal Bladder Tumor With Distinct Coexpression of the Basal Marker Cytokeratin 5/6.
        Am J Clin Pathol. 2021; 155: 588-596
        • Taylor A.S.
        • McKenney J.K.
        • Osunkoya A.O.
        • et al.
        PAX8 expression and TERT promoter mutations in the nested variant of urothelial carcinoma: a clinicopathologic study with immunohistochemical and molecular correlates.
        Mod Pathol. 2020; 33: 1165-1171
        • Legesse T.
        • Matoso A.
        • Epstein J.I.
        PAX8 positivity in nested variant of urothelial carcinoma: a potential diagnostic pitfall.
        Hum Pathol. 2019; 94: 11-15
        • Zhong M.
        • Tian W.
        • Zhuge J.
        • et al.
        Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation.
        Am J Surg Pathol. 2015; 39: 127-131
        • Young R.H.
        • Zukerberg L.R.
        Microcystic transitional cell carcinomas of the urinary bladder. A report of four cases.
        Am J Clin Pathol. 1991; 96: 635-639
        • Lopez-Beltran A.
        • Henriques V.
        • Montironi R.
        • et al.
        Variants and new entities of bladder cancer.
        Histopathology. 2019; 74: 77-96
        • Zukerberg L.R.
        • Harris N.L.
        • Young R.H.
        Carcinomas of the urinary bladder simulating malignant lymphoma. A report of five cases.
        Am J Surg Pathol. 1991; 15: 569-576
        • Manocha U.
        • Kardos J.
        • Selitsky S.
        • et al.
        RNA Expression Profiling of Lymphoepithelioma-Like Carcinoma of the Bladder Reveals a Basal-Like Molecular Subtype.
        Am J Pathol. 2020; 190: 134-144
        • Amin M.B.
        • Ro J.Y.
        • Lee K.M.
        • et al.
        Lymphoepithelioma-like carcinoma of the urinary bladder.
        Am J Surg Pathol. 1994; 18: 466-473
        • Williamson S.R.
        • Zhang S.
        • Lopez-Beltran A.
        • et al.
        Lymphoepithelioma-like carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, and molecular features.
        Am J Surg Pathol. 2011; 35: 474-483
        • Leroy X.
        • Gonzalez S.
        • Zini L.
        • et al.
        Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases.
        Am J Surg Pathol. 2007; 31: 770-773
        • Lopez-Beltran A.
        • Amin M.B.
        • Oliveira P.S.
        • et al.
        Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
        Am J Surg Pathol. 2010; 34: 371-376
        • Borzacchiello G.
        • Ambrosio V.
        • Leonardi L.
        • et al.
        Rare tumours in domestic animals: a lipid cell variant of urothelial carcinoma of the urinary bladder in a cow and a case of vesical carcinosarcoma in a dog.
        Vet Res Commun. 2004; 28: 273-274
        • Mai K.T.
        • Bateman J.
        • Djordjevic B.
        • et al.
        Clear Cell Urothelial Carcinoma.
        Int J Surg Pathol. 2017; 25: 18-25
        • Lopez-Beltran A.
        • Blanca A.
        • Montironi R.
        • et al.
        Pleomorphic giant cell carcinoma of the urinary bladder.
        Hum Pathol. 2009; 40: 1461-1466
        • Wijesinghe H.D.
        • Malalasekera A.
        Giant Cell Urothelial Carcinoma of Bladder.
        Case Rep Urol. 2021; 2021: 8021947
        • Samaratunga H.
        • Delahunt B.
        • Egevad L.
        • et al.
        Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de-differentiation.
        Histopathology. 2016; 68: 533-540
        • Samaratunga H.
        • Delahunt B.
        Recently described and unusual variants of urothelial carcinoma of the urinary bladder.
        Pathology. 2012; 44: 407-418
        • Sanfrancesco J.
        • McKenney J.K.
        • Leivo M.Z.
        • et al.
        Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition.
        Arch Pathol Lab Med. 2016; 140: 543-551
        • Lopez-Beltran A.
        • Pacelli A.
        • Rothenberg H.J.
        • et al.
        Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases.
        J Urol. 1998; 159: 1497-1503
        • Cheng L.
        • Zhang S.
        • Alexander R.
        • et al.
        Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation.
        Am J Surg Pathol. 2011; 35: e34-e46
        • Mori K.
        • Abufaraj M.
        • Mostafaei H.
        • et al.
        A Systematic Review and Meta-Analysis of Variant Histology in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy.
        J Urol. 2020; 204: 1129-1140
        • Genitsch V.
        • Kollar A.
        • Vandekerkhove G.
        • et al.
        Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
        Urol Oncol. 2019; 37: 826-836
        • Guo C.C.
        • Majewski T.
        • Zhang L.
        • et al.
        Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer.
        Cell Rep. 2019; 27: 1781-1793 e4
        • Almassi N.
        • Vertosick E.A.
        • Sjoberg D.D.
        • et al.
        Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy.
        BJU Int. 2022; 129: 463-469
        • Baydar D.
        • Amin M.B.
        • Epstein J.I.
        Osteoclast-rich undifferentiated carcinomas of the urinary tract.
        Mod Pathol. 2006; 19: 161-171
        • Bruins H.M.
        • Visser O.
        • Ploeg M.
        • et al.
        The clinical epidemiology of urachal carcinoma: results of a large, population based study.
        J Urol. 2012; 188: 1102-1107
        • Molina J.R.
        • Quevedo J.F.
        • Furth A.F.
        • et al.
        Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases.
        Cancer. 2007; 110: 2434-2440
        • Pinthus J.H.
        • Haddad R.
        • Trachtenberg J.
        • et al.
        Population based survival data on urachal tumors.
        J Urol. 2006; 175 ([discussion: 2047]): 2042-2047
        • Gopalan A.
        • Sharp D.S.
        • Fine S.W.
        • et al.
        Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.
        Am J Surg Pathol. 2009; 33: 659-668
        • Amin M.B.
        • Smith S.C.
        • Eble J.N.
        • et al.
        Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification.
        Am J Surg Pathol. 2014; 38: 1033-1045
        • Paner G.P.
        • Lopez-Beltran A.
        • Sirohi D.
        • et al.
        Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.
        Adv Anat Pathol. 2016; 23: 71-83
        • Reis H.
        • van der Vos K.E.
        • Niedworok C.
        • et al.
        Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.
        Int J Cancer. 2018; 143: 1764-1773
        • Collazo-Lorduy A.
        • Castillo-Martin M.
        • Wang L.
        • et al.
        Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition.
        Eur Urol. 2016; 70: 771-775
        • Henly D.R.
        • Farrow G.M.
        • Zincke H.
        Urachal cancer: role of conservative surgery.
        Urology. 1993; 42: 635-639
        • Herr H.W.
        • Bochner B.H.
        • Sharp D.
        • et al.
        Urachal carcinoma: contemporary surgical outcomes.
        J Urol. 2007; 178 ([discussion: 78]): 74-78
        • Sheldon C.A.
        • Clayman R.V.
        • Gonzalez R.
        • et al.
        Malignant urachal lesions.
        J Urol. 1984; 131: 1-8
        • Siefker-Radtke A.O.
        • Gee J.
        • Shen Y.
        • et al.
        Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience.
        J Urol. 2003; 169: 1295-1298
        • Wright J.L.
        • Porter M.P.
        • Li C.I.
        • et al.
        Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder.
        Cancer. 2006; 107: 721-728